Diabetics with Coronary Disease Have a Prevalence of Asymptomatic Ischemia during Exercise Treadmill Testing and Ambulatory Ischemia Monitoring Similar to That of Nondiabetic Patients: An ACIP Database Study

Circulation

Volumn 93, Issue 12, 1996, Pages 2097-2105

  Caracciolo, Eugene A ^a,g   Chaitman, Bernard R ^a   Forman, Sandra A ^b   Stone, Peter H ^c   Bourassa, Martial G ^d   Sopko, George ^e   Geller, Nancy L ^e   Conti, C Richard ^f  

^a One University Blvd   (United States)

^b MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Exercise; Ischemia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; TREADMILL ERGOMETRY;

AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; TIME FACTORS;

EID: 0029891402     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.12.2097     Document Type: Article

References (55)

1. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J. 1990;120:672-676.
2. Kannel WB. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100-1107.
3. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation. 1979;59:8-13.
4. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
5. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol. 1974;34: 29-34.
6. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham Study. N Engl J Med. 1984;311:1144-1147.
7. Cabin HS, Roberts WC. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ('silent') previous acute myocardial infarction. Am J Cardiol. 1982;50:677-681.
8. Soler NG, Bennett MA, Pentecost BL, Fitzgerald MG, Malins JM. Myocardial infarction in diabetics. Q J Med. 1975;44:125-132.
9. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction - silent and symptomatic: eighteen-year follow-up: the Framingham Study. Am J Cardiol. 1974;32:1-7.
10. Bradley RF, Partamian JO. Coronary heart disease in the diabetic patient. Med Clin North Am. 1963;49:1093-1104.
11. Bradley RF, Schonfeld A. Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics. 1962;17:322-326.
12. Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD. Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol. 1993; 22:1433-1437.
13. Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S, Ishihara F, Niwa A, Yamada T. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J. 1992;123:46-53.
14. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS Jr. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med. 1988;108:170-175.
15. Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M. Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J. 1985;110: 529-534.
16. Callaham PR, Froelicher VF, Klein J, Risch M, Dubach P, Friis R. Exercise-induced silent ischemia: age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol. 1989;14: 1175-1180.
17. Chipkin SR, Frid D, Alpert JS, Baker SP, Dalen JE, Aronin N. Frequency of painless myocardial ischemia during exercise tolerance testing in patients with and without diabetes mellitus. Am J Cardiol. 1987;59:61-65.
18. Faerman I, Faccio E, Milei J, Nunez R, Jadzinsky M, Fox D, Rapaport M. Autonomie neuropathy and painless myocardial infarction in diabetic patients. Diabetes. 1977;26:1147-1158.
19. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol. 1991;67:1073-1078.
20. Murray DP, O'Brien T, Mulrooney R, O'Sullivan DJ. Autonomic dysfunction and silent myocardial ischemia on exercise testing in diabetes mellitus. Diabet Med. 1990;7:580-584.
21. Niakan E, Harati Y, Rolak L, Comstock J, Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med. 1986;146:2229-2230.
22. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects of diabetic autonomic neuropathy and prognostic implications. Ann Intern Med. 1980;92:308-311.
23. Ewing D, Campbell I, Clarke B. The natural history of diabetic autonomie neuropathy. Q J Med. 1980;49:95-108.
24. Pepine CJ, Geller NL, Knatterud GL, Bourassa MG, Chaitman BR, Davies RF, Day P, Deanfield JE, Goldberg AD, McMahon RP, Mueller H, Ouyang P, Pratt C, Proschan M, Rogers WJ, Selwyn AP, Sharaf B, Sopko G, Stone PH, Conti CR, for the ACIP Investigators. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol. 1994;24:1-10.
25. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, Pratt C, Stone PH, Davies RF, Rogers WJ, Deanfield JE, Goldberg AD, Ouyang T, Hueller H, Sharaf B, Day P, Selwyn AP, Conti CR, for the ACIP Investigators. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischemia pilot (ACIP) study. J Am Coll Cardiol. 1994;24:11-20.
26. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman S, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine C, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR, for the ACIP Investigators. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: outcome at one year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol. 1995;26:594-605.
27. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76: 142-154.
28. Tamesis B, Stelken A, Byers S, Shaw L, Younis L, Miller DD, Chaitman BR. Comparison of the asymptomatic cardiac ischemia pilot and modified asymptomatic cardiac ischemia pilot versus Bruce and Cornell exercise protocols. Am J Cardiol. 1993;72: 715-720.
29. Hartigan PM, Parisi AF, Folland ED, for the Veterans Affairs ACME Investigators. Angina-free time on the treadmill as an alternate method for evaluating antianginal therapy. Am J Cardiol. 1994;72:516-518.
30. Kaplan KL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
31. Conti CR, Knatterud GL, Sopko G. Correction. J Am Coll Cardiol. 1995;26:842.
32. Assmann G, Schulte H. The Prospective Munster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116:1713-1724.
33. Robertson W, Strong J. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:538-551.
34. Waller B, Palumbo P, Roberts W. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Am J Med. 1980;69:498-506.
35. Baroldi G, Falzi G, Mariani F. Sudden coronary death: a postmortem study in 208 selected cases compared to 97 'control' subjects. Am Heart J. 1979;98:20-31.
36. Hamby R, Sherman L, Mehta J, Aintablian A. Reappraisal of the role of the diabetic state in coronary artery disease. Chest. 1976;70: 251-257.
37. Crall FV, Roberts W. The extramural and intramural coronary arteries in juvenile diabetes mellitus. Am J Med. 1978;64:221-230.
38. Dortimer A, Shenoy P, Shiroff R, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetics: fact or fiction? Circulation. 1978;57:133-136.
39. Ranjadayalan K, Umachandran V, Ambepityia G, Kopelman PG, Mills PG, Timmis AD. Prolonged anginal perceptual threshold in diabetes: effects on exercise capacity and myocardial ischemia. J Am Coll Cardiol. 1990;16:1120-1124.
40. Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomie function. J Am Coll Cardiol. 1990;15:72-77.
41. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, Tristani FE. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol. 1991;68:729-734.
42. Hinderliter A, Miller P, Bragdon E, Ballender M, Sheps D. Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand. J Am Coll Cardiol. 1991;18:405-412.
43. Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation. 1990;82:1296-1304.
44. Mulcahy D, Keegan J, Sparrow J, Park A, Wright C, Fox K. Ischemia in the ambulatory setting - the total ischemic burden: relation to exercise testing and investigative and therapeutic implications. J Am Coll Cardiol. 1989;14:1166-1172.
45. Tzivoni D, Gavish A, Benhorin J, Keren A, Stern S. Myocardial ischemia during daily activities and stress. Am J Cardiol. 1986;58: 47B-50B.
46. Campbell S, Barry J, Rocco MB, Nabel EG, Mead-Walters K, Rebecca GS, Selwyn AP. Features of the exercise test that reflect the activity of ischemic heart disease out of hospital. Circulation. 1986;74:72-80.
47. Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro GM, Fazzini PF. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol. 1983;1:934-939.
48. Deanfield JE, Selwyn AP, Chierchia S, Maseri A, Ribeiro P, Krikier S. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet. 1983;2:753-758.
49. Schang SJ, Pepine CJ. Transient asymptomatic ST-segment depression during daily activity. Am J Cardiol. 1977;39:396-402.
50. Andrews TC, Fenton T, Toyosaki N, Glasser SP, Young PM, MacCallum G, Gibson RS, Shook T, Stone PH, for the Angina and Silent Ischemia Study Group (ASIS). Subsets of ambulatory myocardial ischemia based on heart rate activity: circadian distribution and response to anti-ischemic medication. Circulation. 1993;88: 92-100.
51. Strano A, Novo S, Raineri A, Alaimo G, Abrignani MG, Immordino R, Nardi E, Giuliano F. Asymptomatic episodes of ischemia and their relation to heart rate changes in patients with chronic ischemia heart disease. Eur Heart J. 1988;9:N11-N14.
52. Quyyumi AA, Efthimiou J, Quyyumi A, Mockus LJ, Spiro SG, Fox KM. Nocturnal angina: precipitating factors in patients with coronary artery disease and those with variant angina. Br Heart J. 1986; 56:346-352.
53. Quyyumi AA, Wright CA, Mockus LJ, Fox KM. Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease. Lancet. 1984;1:1207-1209.
54. Chierchia S, Gallina A, Smith G, Deanfield J, Morgan M, Croom M, Maseri A. Role of heart rate in the pathophysiology of chronicstable angina. Lancet. 1984;2:1353-1357.
55. Davies AB, Bala Subramanian V, Cashman PM, Raftery EB. Simultaneous recording of continuous arterial pressure, heart rate, and ST segment in ambulant patients with stable angina pectoris. Br Heart J. 1983;50:85-91.